[Research progress in medicines on protease-activated receptor 2]

Area of Science:

• Molecular biology
• Pharmacology
• Immunology

Background:

• Protease-activated receptor 2 (PAR2) is implicated in various physiological and pathological processes.
• PAR2 is expressed in diverse tissues, including skin and airway epithelial cells, contributing to conditions like asthma, pain, and inflammation.
• Dysregulation of PAR2 signaling is linked to the pathogenesis of numerous diseases.

Purpose of the Study:

• To review the current research on PAR2.
• To explore the therapeutic potential of targeting PAR2.
• To summarize advancements in PAR2 agonists, antagonists, and pepducins.

Main Methods:

• Literature review of studies on PAR2.
• Analysis of research progress on PAR2 modulators.
• Synthesis of information on agonist, antagonist, and pepducin development for PAR2.

Main Results:

• PAR2 modulators, including agonists, antagonists, and pepducins, are under investigation.
• These agents show promise in preclinical models for conditions involving PAR2.
• The development of specific PAR2-targeting drugs is an active area of research.

Conclusions:

• Intervention targeting PAR2 is a promising strategy for disease treatment.
• Further research into PAR2 modulators could lead to novel therapeutic agents.
• Understanding PAR2's role is crucial for developing new drugs for inflammatory and pain-related conditions.